Endocannabinoids drive the acquisition of an alternative phenotype in microglia

Arévalo-Martín, 2008, CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies, Br. J. Pharmacol., 153, 216, 10.1038/sj.bjp.0707466

Bisogno, 2003, Cloning the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain, J. Cell Biol., 163, 436, 10.1083/jcb.200305129

Bisogno, 2010, Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders, CNS Neurol. Disord., 9, 564, 10.2174/187152710793361568

Cabral, 2009, Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation, Expert Rev. Mol. Med., 11, e3, 10.1017/S1462399409000957

Carlisle, 2002, Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation, Int. Immunopharmacol., 2, 69, 10.1016/S1567-5769(01)00147-3

Carrier, 2004, Cultured rat microglia synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism, Mol. Pharmacol., 65, 999, 10.1124/mol.65.4.999

Carrillo-Salinas, 2014, A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis, PLoS One, 20, 4707

Centonze, 2007, The endocannabinoid system in targeting inflammatory neurodegenerative diseases, Trends Pharmacol. Sci., 28, 180, 10.1016/j.tips.2007.02.004

Chhor, 2013, Characterization of phenotype markers and neuronotoxic potential of polarized primary microglia in vitro, Brain Behav. Immun., 32, 70, 10.1016/j.bbi.2013.02.005

Chiurchiù, 2014, Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor, Atherosclerosis, 233, 55, 10.1016/j.atherosclerosis.2013.12.042

Colton, 2009, Heterogeneity of microglial activation in the innate immune response in the brain, J. Neuroimmune Pharmacol., 4, 399, 10.1007/s11481-009-9164-4

Cravatt, 2003, Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system, Curr. Opin. Chem. Biol., 7, 469, 10.1016/S1367-5931(03)00079-6

Correa, 2009, A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglia, Biochem. Pharmacol., 77, 86, 10.1016/j.bcp.2008.09.014

Di Marzo, 2011, Endocannabinoid signaling in the brain: biosynthetic mechanisms in the timelight, Nat. Neurosci., 14, 9, 10.1038/nn.2720

Di Marzo, 1999, Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages, Eur. J. Biochem., 264, 258, 10.1046/j.1432-1327.1999.00631.x

Dirikoc, 2007, Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity, J. Neurosci., 27, 9537, 10.1523/JNEUROSCI.1942-07.2007

Durafourt, 2013, Isolating, culturing and polarizing primary human adult and fetal microglia, 199

Ehrhart, 2005, Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation, J. Neuroinflam., 2, 29, 10.1186/1742-2094-2-29

Eljaschewitsch, 2006, The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells, Neuron, 49, 67, 10.1016/j.neuron.2005.11.027

Feliú, A., Moreno-Martet, M., Mecha, M., Carrillo-Salinas, F.J., de Lago, E., Fernández-Ruiz, J., Guaza, C. A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Br. J. Pharmacol. 2015 (Epub ahead of print).

Fowler, 2012, Anandamide uptake explained?, Trends Pharmacol. Sci., 33, 181, 10.1016/j.tips.2012.01.001

Freund, 2003, Role of endogenous cannabinoids in synaptic signaling, Physiol. Rev., 83, 1017, 10.1152/physrev.00004.2003

García-Ovejero, 2013, Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signaling, Biochem. Soc. Trans., 41, 1577, 10.1042/BST20130198

Gokoh, 2007, 2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells, Biol. Pharm. Bull., 30, 1199, 10.1248/bpb.30.1199

Gómez, 2010, The constitutive production of the endocannabinoide 2-arachidonoylglycerol participates in oligodendrocyte differentiation, Glia, 58, 1913, 10.1002/glia.21061

Gonsiorek, 2000, Endocannabinoid 2-arachidonylglycerol is a full agonist through human type 2 cannabinod receptor: antagonism by anandamide, Mol. Pharmacol., 57, 1045

Gordon, 2003, Alternative activation of macrophages, Nat. Rev. Immunol., 3, 23, 10.1038/nri978

Griffin, 2000, Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor, J. Pharmacol. Exp. Ther., 292, 886

Hernangómez, 2014, Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200–CD200R interaction involve the cannabinoid system, Curr. Pharm. Des., 20, 4707, 10.2174/1381612820666140130202911

Hernández-Torres, 2014, A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis, Angew. Chem. Int. Ed., 53, 13765, 10.1002/anie.201407807

Hillard, 2000, Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol, Prostaglandins Other Lipids Mediat., 61, 3, 10.1016/S0090-6980(00)00051-4

Hu, 2015, Microglial and macrophage polarization-new prospects for brain repair, Nat. Rev. Neurol., 11, 56, 10.1038/nrneurol.2014.207

Litchman, 2010, Endocannabinoid overload, Mol. Pharmacol., 78, 993, 10.1124/mol.110.069427

Liu, 2003, Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activated factor, J. Biol. Chem., 278, 45034, 10.1074/jbc.M306062200

Liu, 2006, Novel biosynthetic pathway for anandamide, Proc. Natl. Acad. Sci. U.S.A., 103, 13345, 10.1073/pnas.0601832103

MacMicking, 1997, Nitric oxide and macrophage function, Annu. Rev. Immunol., 15, 323, 10.1146/annurev.immunol.15.1.323

McCarthy, 1980, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell Biol., 85, 890, 10.1083/jcb.85.3.890

Maresz, 2005, Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli, J. Neurochem., 95, 437, 10.1111/j.1471-4159.2005.03380.x

Maroof, 2013, Endocannabinoid signalling in Alzheimer’s disease, Biochem. Soc. Trans., 41, 1583, 10.1042/BST20130140

Martín-Couce, 2012, Chemical probes for the recognition of cannabinoid receptors in native systems, Angew. Chem. Int. Ed., 51, 6896, 10.1002/anie.201200467

Mechoulam, 2013, The endocannabinoid system and the brain, Ann. Rev. Psychol., 64, 21, 10.1146/annurev-psych-113011-143739

Medina-Rodríguez, 2013, Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans, PLoS One, 8, e81620, 10.1371/journal.pone.0081620

Melief, 2012, Phenotyping primary human microglia: tight regulation of LPS responsiveness, Glia, 60, 1506, 10.1002/glia.22370

Miller, 2011, The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications, Pharmacol. Rev., 63, 461, 10.1124/pr.110.003491

Murataeva, 2014, Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS, Br. J. Pharmacol., 171, 1379, 10.1111/bph.12411

Neumann, 2009, Debris clearance by microglia: an essential link between degeneration and regeneration, Brain, 132, 288, 10.1093/brain/awn109

Novak, 2013, Macrophage phenotypes during tissue repair, J. Leukoc. Biol., 93, 875, 10.1189/jlb.1012512

Ortega-Gutiérrez, 2005, Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis, FASEB J., 19, 1338, 10.1096/fj.04-2464fje

Pacher, 2008, The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol. Rev., 58, 389, 10.1124/pr.58.3.2

Pertwee, 2010, Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists, Curr. Med. Chem., 17, 1360, 10.2174/092986710790980050

Raes, 2005, Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation, J. Leukoc. Biol., 77, 321, 10.1189/jlb.0304212

Ramírez, 2005, Prevention of Alzheimeŕs disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation, J. Neurosci., 25, 1904, 10.1523/JNEUROSCI.4540-04.2005

Salzet, 2000, Comparative biology of the endocannabinoid system: possible role in the immune response, Eur. J. Biochem., 267, 4917, 10.1046/j.1432-1327.2000.01550.x

Shiratsuchi, 2008, Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis, Immunol. Cell Biol., 86, 179, 10.1038/sj.icb.7100121

Simon, 2006, Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta hydrolase 4 in this pathway, J. Biol. Chem., 281, 26465, 10.1074/jbc.M604660200

Spittau, 2013, Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro, Glia, 61, 287, 10.1002/glia.22435

Spittau, 2015, TGFß1 increases microglia-mediated engulfment of apoptotic cells via upregulation of the milk fat globule-EGF factor 8, Glia, 63, 142, 10.1002/glia.22740

Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J. Exp. Med., 176, 287, 10.1084/jem.176.1.287

Stella, 1997, A second endogenous cannabinoid that modulates long-term potentiation, Nature, 338, 773, 10.1038/42015

Stella, 2009, Endocannabiniod signaling in microglial cells, Neuropharmacology, 56, 244, 10.1016/j.neuropharm.2008.07.037

Tolón, 2009, The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages, Brain Res., 1283, 148, 10.1016/j.brainres.2009.05.098

Walter, 2003, Non-psychotropic cannabinoid receptors regulate microglial cell migration, J. Neurosci., 23, 1398, 10.1523/JNEUROSCI.23-04-01398.2003

Zhang, 2003, Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models, Eur. J. Neurosci., 17, 2750, 10.1046/j.1460-9568.2003.02704.x